<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04341597</url>
  </required_header>
  <id_info>
    <org_study_id>PI2018_843_0037</org_study_id>
    <nct_id>NCT04341597</nct_id>
  </id_info>
  <brief_title>Evaluation of Transperineal Ultrasound Technic for Diagnostic Shorted Cervical Length for Pregnant Women (2nd and 3rd Trimester) Compared to Endovaginal Technic (Gold Standard)</brief_title>
  <acronym>ECHO</acronym>
  <official_title>Evaluation of Transperineal Ultrasound Technic for Diagnostic Shorted Cervical Length for Pregnant Women (2nd and 3rd Trimester) Compared to Endovaginal Technic (Gold Standard)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endovaginal ultrasound is currently the gold standard to diagnose a shorted cervical length&#xD;
      and, by extension, assess the risk of preterm labor. The major inconvenient is that this is&#xD;
      an invasive method of diagnosis that tends to be poorly accepted by some patients. This study&#xD;
      aims to evaluate the accuracy of a noninvasive transperineal ultrasound cervical measurement&#xD;
      in comparison to the endovaginal technic in 2nd and 3nd trimester pregnant women where a&#xD;
      cervical ultrasound is indicated.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The cervical length is a crucial part of the diagnostic of premature labor. The gold standard&#xD;
      technic is the endovaginal ultrasound. This is a technic with good reproducibility and good&#xD;
      precision. Some authors have found the transperineal technic to present the same&#xD;
      characteristics, without being as invasive. The aim of the study was to compare the results&#xD;
      of the less invasive technic to the current invasive gold standard in pregnant women who&#xD;
      consult for contraction, or for whom cervical modification is suspected in order to determine&#xD;
      whether the former could replace the latter.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 6, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Actual">September 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>difference of measurement of the uterine cervix</measure>
    <time_frame>at day 0</time_frame>
    <description>difference of measurement of the uterine cervix will be done by analysing the variation between the transperineal measurement and endovaginal evaluation of the uterine cervix. Length will be measured in millimetres</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">74</enrollment>
  <condition>Ultrasound</condition>
  <condition>Transperineal</condition>
  <arm_group>
    <arm_group_label>transperineal sonographic cervix assessment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>endovaginal sonographic cervix assessment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>cervical ultrasound</intervention_name>
    <description>All volunteer patients for whom a cervical ultrasound is indicated will have with a first operator the performing the usual technic, and with a second operator performing the trans perineal technic without being aware of the first measurement.</description>
    <arm_group_label>endovaginal sonographic cervix assessment</arm_group_label>
    <arm_group_label>transperineal sonographic cervix assessment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pregnant women between 2nd and 3rd trimester consulting in obstetric emergency for&#xD;
             whom a cervical ultrasound is indicated&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  minor patients&#xD;
&#xD;
          -  mentally deficient persons&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Julien Chevreau, MD</last_name>
    <phone>(33)3 22 08 74 52</phone>
    <email>chevreau.julien@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80480</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>julien chevreau, MD</last_name>
      <phone>(33)3 22 08 74 52</phone>
      <email>chevreau.julien@chu-amiens.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 6, 2020</study_first_submitted>
  <study_first_submitted_qc>April 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 10, 2020</study_first_posted>
  <last_update_submitted>July 8, 2021</last_update_submitted>
  <last_update_submitted_qc>July 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>endovaginal</keyword>
  <keyword>ultrasound</keyword>
  <keyword>transperineal</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

